Eisman J A, Sutherland R L, McMenemy M L, Fragonas J C, Musgrove E A, Pang G Y
Garvan Institute of Medical Research, St Vincent's Hospital, Sydney, N.S.W., Australia.
J Cell Physiol. 1989 Mar;138(3):611-6. doi: 10.1002/jcp.1041380323.
The replication of several human and animal cancer cell lines is regulated in vitro and in vivo by 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3], the hormonally active form of vitamin D3. We have examined the effects of concentrations of 1,25-(OH)2D3, which inhibit cellular replication, on the cell-cycle kinetics of a 1,25-(OH)2D3-responsive human breast cancer cell line, T 47D. After 6 or 7 days of treatment, a time period representing approximately five cell population doublings of control cultures, concentrations of 1,25-(OH)2D3 in the range 10(-9) M to 10(-6) M caused a time- and concentration-dependent decrease in cell numbers. Treatment of cells growing in charcoal-treated fetal calf serum with 10(-8) M 1,25-(OH)2D3 for 6 days reduced cell numbers to 49% +/- 9% (n = 9) of control, and this was associated with a marked increase in the proportion of cells in the G2 + M phase of the cell cycle from 9.7% +/- 0.5% (n = 11) to 19.6% +/- 2.3% (n = 9), significant by paired analysis (P less than 0.002). At higher concentrations of 1,25-(OH)2D3 (10(-7)-10(-6) M), there was a concentration-dependent decline in S phase and increases in both G0/G1 and G2 + M phase cells. Detailed analysis of the temporal changes in cell-cycle phase distribution following treatment with 2.5 X 10(-8) and 10(-7) M 1,25-(OH)2D3 showed an initial accumulation of cells in G0/G1 and depletion of S phase cells during the first 24 hr of treatment. This decline in S phase cells was not accompanied by a decline in % G2 + M indicating a transition delay in G2 or mitosis. At the lower dose these changes returned to control values at 48 hr and at later times were associated with a slight but consistent decline in G0/G1 phase and an increase in G2 + M. In contrast cells treated with 10(-7) M 1,25-(OH)2D3 had significantly elevated % G0/G1 cells at days 2 and 3, consistent with a transition delay through G1 phase. This was confirmed in stathmokinetic experiments which demonstrated an approximate sevenfold decrease in the rate of exit of cells from G0/G1 following 4 days of exposure to 10(-7) M 1,25-(OH)2D3. This accumulation of cells in G0/G1 was accompanied by a fall in % S phase cells.(ABSTRACT TRUNCATED AT 400 WORDS)
1,25 - 二羟基维生素D3[1,25-(OH)2D3]是维生素D3的激素活性形式,它在体外和体内对多种人类及动物癌细胞系的增殖具有调节作用。我们研究了抑制细胞增殖的1,25-(OH)2D3浓度对一种对1,25-(OH)2D3有反应的人乳腺癌细胞系T 47D细胞周期动力学的影响。在处理6或7天后,这一时间段约相当于对照培养物的五个细胞群体倍增时间,10(-9)M至10(-6)M范围内的1,25-(OH)2D3浓度导致细胞数量出现时间和浓度依赖性减少。用10(-8)M 1,25-(OH)2D3处理在经活性炭处理的胎牛血清中生长的细胞6天,细胞数量降至对照的49%±9%(n = 9),这与细胞周期G2 + M期细胞比例从9.7%±0.5%(n = 11)显著增加至19.6%±2.3%(n = 9)相关,配对分析显示差异有统计学意义(P < 0.002)。在更高浓度的1,25-(OH)2D3(10(-7)-10(-6)M)下,S期呈浓度依赖性下降,G0/G1期和G2 + M期细胞均增加。对用2.5×10(-8)和10(-7)M 1,25-(OH)2D3处理后细胞周期阶段分布的时间变化进行详细分析表明,在处理的最初24小时内,细胞在G0/G1期初始积累,S期细胞减少。S期细胞的这种减少并未伴随G2 + M期百分比的下降,表明在G2期或有丝分裂期存在过渡延迟。在较低剂量下,这些变化在48小时时恢复到对照值,在随后的时间里与G0/G1期略有但持续的下降以及G2 + M期增加相关。相比之下,用10(-7)M 1,25-(OH)2D3处理的细胞在第2天和第3天G0/G1期细胞百分比显著升高,这与通过G1期的过渡延迟一致。这在静止动力学实验中得到证实,该实验表明在暴露于10(-7)M 1,25-(OH)2D3 4天后,细胞从G